News
HPV awareness could save thousands from cervical cancer in low-resource nations – report

A widespread lack of awareness of how a common virus is the primary cause of cervical cancer is leading to thousands of needless deaths every year, concludes a global report.
But embracing more advanced screening tools and the willingness of more women to self-collect health data could be pivotal in addressing the issue.
That is according to a study spanning 12 countries in Europe and Latin America commissioned by the pharmaceutical giant Roche.
Half of those polled had either limited or no awareness of the important role human papillomavirus (HPV) plays in cervical cancer.
HPV is a common virus transmitted through sexual contact and is the primary cause of cervical cancer, responsible for over 99 per cent of cases.
Every year, more than 600,000 women worldwide are diagnosed with cervical cancer and over 340,000 die, with nine in every ten of these women living in low-resource countries.
However, 93 per cent of cervical cancers could be prevented entirely through appropriate screening and HPV vaccination.
The research also demonstrates that with screening rates varying between regions, significant barriers continue to exist that are preventing women from seeking testing.
Respondents in all countries, including both developed and developing nations, reported that concerns about the testing procedure being painful were common – up to 63 per cent in some countries.
Also cited was a sense of discomfort about discussing their sexual history or sexuality with a healthcare provider – up to 57 per cent in some countries.
Joanna Sickler, vice-president, health policy and external affairs at Roche Diagnostics, said: “Thousands of women are needlessly dying from cervical cancer every year. This survey highlights some of the most important barriers to screening, as well as the opportunities we have to prevent disease and improve women’s health.
“With many women reporting being open to new screening tools like self-collection, it has never been more important that communities, health systems, governments and innovators come together to seize this opportunity, and provide the early detection and treatment needed to avoid so many preventable deaths.”
The World Health Organisation is focused on accelerating the elimination of cervical cancer globally, with its latest guidelines recommending HPV DNA testing as primary screening for all women.
Its strategy seeks to ensure that by 2030, 90 per cent of girls are fully vaccinated against HPV by age 15.
It also aims for 70 per cent of women to have been screened using a high-performance test by age 35, and again by age 45, with 90% of those eligible linked to treatment.
This, along with vaccination against HPV, could prevent more than 62 million deaths in the next 100 years.
More than 50 per cent of new cervical cancers occur in women who have never been screened, or have not been screened in the previous five years of their lives.
Many factors can contribute to individuals not participating in cervical cancer screening programs, such as access to healthcare, social and economic barriers, history of traumatic experience, cultural concerns and embarrassment.
The many barriers preventing women from seeking HPV screening could explain the widespread interest in self-testing revealed by the survey.
In European countries, where testing is more routinely available, 57 per cent of women were interested in the opportunity to collect their own samples for testing. This figure rose to 77 per cent in Latin American countries, where routine screening is less readily available because of a lack of infrastructure and available appointment means.
This discrepancy was also reflected in healthcare professional-reported results, which showed 72 per cent of healthcare professionals and government workers in Latin American countries agree their country needs a self-collection programme, compared to 48% in Europe.
Susana Wong, patient advocate and director of Lazo Rosado, Perú, is working to expand access to HPV testing in her country.
She said: “We know very well how to prevent and treat cervical cancer. Now, with HPV molecular tests and vaccination, there really is hope to eliminate this disease. This test gives you the opportunity to live and to live well with your family. It can help women to empower themselves as to their health.”
Men demonstrated even lower levels of awareness compared to women, particularly in Europe.
While 55 per cent to 76 per cent of men in Latin America reported some understanding of HPV, only 35 per cent to 51 per cent of men in Europe had any understanding of HPV at all.
The lower awareness among men highlights the need for educational initiatives to include men, given their potential role in the transmission and prevention of HPV, says the report.
“This survey highlights both the challenges ahead and the significant opportunities we have to advance HPV prevention,” Sickler said.
“By enhancing public education about HPV risks and reimagining how we deliver care, we can drive higher screening rates and make meaningful progress in combating cervical cancer.”
Fighting cervical cancer
Screening for HPV can help identify women who are at risk of developing cervical cancer, so that the disease can be treated early before invasive cancer has a chance to develop.
In poorer countries, women are often diagnosed with cervical cancer at a more advanced stage, where the opportunity for a cure is low.
Last mont, Roche joined the Global HPV Consortium which aims to advance cervical cancer prevention efforts and raise the prominence of early screening and timely detection using high-performance HPV-DNA tests.
Conducted in Q1 2024, the HPV Health Understanding Survey involved 8,703 men and women across 12 countries.
It also measured perceptions among 2,585 healthcare professionals (HCPs) and government professionals of HPV testing availability in their own market.
News
What “women’s healthmaxxing” means for patient trust and the femtech industry

Women’s health has become one of the most searched and shared topics online, from cycle syncing and cortisol management to menopause hacks, supplements, hormone testing and clinician-creator content.
That surge in attention, sometimes dubbed “healthmaxxing,” is changing how women find, evaluate and act on health information, and it is starting to reshape the relationship between patients, clinicians and the companies building products for this market.
For providers, the shift means patients are arriving better informed but also more exposed to unverified claims, putting pressure on clinicians to engage with online narratives rather than dismiss them.
For femtech and pharma companies, it opens a route to reach and educate consumers at scale, but also raises the stakes on credibility: products and messaging that ride the trend without clinical grounding risk eroding the trust the industry has spent years building.
Investors are watching the same dynamic from a different angle.
Attention-driven demand can be a signal of where the next wave of femtech growth will come from, but distinguishing genuine clinical need from viral momentum is increasingly part of due diligence.
The net effect is a widening gap between companies that treat cultural attention as a distribution channel for credible, evidence-based care, and those that risk being swept up in trends with little clinical substance behind them.
How that gap plays out will shape patient trust, clinical relationships and commercial opportunity across the women’s health industry for years to come.
These themes will be explored in more depth in an upcoming webinar, “Women’s Healthmaxxing: The Opportunity & Risks of Cultural Attention for the Women’s Health Industry,” hosted by the Women’s Health Innovation Summit (WHIS), featuring Ellen Wilcox (Listen Ventures), Jessica Bell van der Wal (Frame Fertility), Dr. Tosin Sotubo-Ajayi (NHS, BBC and more) and Nora Lansen (Elektra Health).
Register free for the webinar on 23 July 2026 at https://events.virtualpro.com/womens-health-series-webinar-july-2026/registration
Insight
Rising number of young midwives quitting NHS due to burnout

More young midwives are leaving the NHS before 35 as burnout adds pressure to stretched maternity services, new research has revealed.
The trend has raised concerns about the quality and safety of care for mothers and babies in understaffed maternity units.
During 2025-26, 1,669 midwives aged 34 or under left the health service in England, representing 57 per cent of the 2,949 midwives of all ages who resigned.
The pressures of maternity care, including increasingly complex childbirth and the risks involved, are thought to be among the factors behind the trend.
Hannah Leonard, deputy chief midwife at the Royal College of Midwives, said the exodus of midwives under 35 was “deeply worrying” and showed that too many were ending up “burnt-out within a few years of qualifying because every shift means too few colleagues, missed breaks and unpaid hours”.
She added: “Losing these midwives, and students, even before they qualify, is a terrible waste of talent.”
The figures, revealed in parliamentary questions tabled by the Liberal Democrats, show that 205 of last year’s younger leavers were under 25, while 655 were aged 25 to 29 and 809 were aged 30 to 34.
The number of midwives under 35 leaving the NHS has risen sharply in recent years. The 2025-26 figure was 59 per cent higher than the 1,051 who left in 2014-15, according to NHS figures.
Burnout means long-term physical and emotional exhaustion, often linked to sustained pressure at work.
Separate figures obtained by the Liberal Democrats suggest almost one in four midwifery students are leaving before completing their three-year degree.
In 2021, 3,565 students started a midwifery degree, but 2,725 graduated in 2024, meaning 840, or 24 per cent, did not complete the course.
Midwifery students spend much of their second and third years learning on the job in maternity units.
The loss of staff and students underlines what the Royal College of Midwives has described as a “staffing emergency” in maternity care across the UK.
A recent survey by the Royal College of Midwives found that three-quarters of midwives had considered leaving the profession over the last year, mainly because of concerns over staffing levels and patient safety.
Both recent large-scale reviews of maternity care in England, led by Donna Ockenden and Valerie Amos, identified staffing shortages as a key problem affecting patient safety.
Helen Morgan, the Liberal Democrat health spokesperson, said: “These statistics reveal an alarming crisis in maternity, with far too many midwives burning out early in their career and in their training. Patients are paying the price, and mothers are left with no alternative but to give birth on understaffed and unsafe wards.
“Rather than throw money at yet more new recruits who quit under intolerable pressure, the government needs a new approach. Through guaranteeing protected, year-round training and professional development we can help midwives cope with rising complexity and risk.”
About 10 per cent of all midwives leave the NHS each year.
However, the figures show higher leaving rates among younger midwives, with one in seven, or 14.6 per cent, of those aged 25 to 29 and one in six, or 16.6 per cent, of those aged 30 to 34 leaving during 2025-26.
A Department of Health and Social Care spokesperson said: “Under this government we have a record number of midwives in the workforce and we value the vital service they provide in maternity and neonatal units across the country.
“To make the NHS the best employer it can be, we have introduced new NHS staff standards to improve health and wellbeing support, promote flexible working, as well as crucial measures to tackle violence, sexual harassment or abuse and racism.
“Alongside consecutive above-inflation pay rises, we’ve bolstered the midwifery workforce through our graduate guarantee and recently opened up 1,000 more midwifery roles backed by £10m to help prevent student midwives leaving the profession.”
Department of Health and Social Care figures show a record 25,500 full-time-equivalent midwives are working in the NHS, 2,000 more than when the Labour government took office in July 2024.
Mental health
Nearly 60% of young women get health advice from influencers, research finds

Nearly six in ten young women get health and wellness advice from influencers, new research shows.
Women aged 18 to 29 were more likely than young men to use online influencers for health information.
The topics included beauty, alternative medicine, mental health, weight loss and fitness.
The Pew Research study found that 57 per cent of women aged 18 to 29 said they get health and wellness information from online influencers, 10 percentage points higher than young men.
While Americans still mostly rely on healthcare providers, the research suggests social media influencers also play a major role in how young people find health advice.
Among women who get health and wellness information from influencers, 51 per cent said they often hear about beauty and appearance, compared with 18 per cent of men.
Young women were also around twice as likely as young men to say they see content about alternative medicine, meaning treatments or health practices used outside mainstream medical care.
A third or more of both young men and young women said they often hear about mental health and weight loss from influencers.
Around half or more of both groups said they often see fitness content.
When asked why they seek health and wellness information from influencers, around half of young women said they wanted to make a change to their health or lifestyle.
That compared with 37 per cent of young men.
The research also found that 23 per cent of young women said hearing from people who share their background or beliefs was one reason they used influencers, compared with 14 per cent of young men.
A further 19 per cent of young women said they learnt about things they did not want to ask their doctor, compared with 10 per cent of young men.
Diagnosis2 weeks agoTwo “gamechanger” tests set to speed up endometriosis diagnosis on the NHS
Insight2 weeks agoWomen with PMOS should have annual NHS checks, new guidance says
News5 days agoNew menopause drug approved for use by NHS in Scotland
Cancer2 weeks agoThousands of women could avoid painful cancer exam with new AI blood test
Entrepreneur2 weeks agoApplications open for the third W Accelerate with Merck KGaA and M Ventures
Fertility2 weeks agoOlder women face lower chance of fertility treatment working, even with donor eggs, study finds
News2 weeks agoWe built Ema like a nurse: Here’s why that matters
News2 weeks agoExperts call for regulation of toxic period product chemicals











